1. Amstutz, R., Ringdahl, B., Karlén, B., Roch, M., and Jenden, D. J. (1985) Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(Tertiary amino)-2-butynyl]-5methyl-2-pyrrolidones. J. Med. Chem.28, 1760–1765.
2. Amstutz, R., Closse, A., and Gmelin, G. (1987) Die Position 5 im Oxotremoringeruest: Eine zentrale Stelle fuer die Steuerung der Aktivitaet am muskarinischen Rezeptor. Heiv. Chim. Acta70, 2232–2244.
3. Angeli, P., Brasili, L., Giardina, D., and Melchiorre, C. (1981) Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarines. J. Pharmaceut. Sci.70, 489–492.
4. Angeli, P., Brasili, L., Giannella, M., Gualtieri, F., Picchio, M. T., and Teodori, E. (1988) Chiral muscarinic agonists possessing a 1,3-oxathiolane nucleus: enantio-and tissue-selectivity on isolated preparations of guinea-pig ileum and atria and of rat urinary bladder. Naunyn-Schmiedeberg’s Arch. Pharmacol.337, 241–245.
5. Angell, P., Giannella, M., Pigini, M., Gualtieri, F., and Cingolani, M. L. (1984) Size of muscarinic receptor anionic binding site related to onium group of ligands with a 1,3-oxathiolane nucleus. Eur. J. Med. Chem. 19, 495–500.